Crucell

Crucell is a global biopharmaceutical company dedicated to bringing meaningful innovation to global health. Through discovering, developing, manufacturing, and marketing products, Crucell combats major threats to the health of people worldwide, specializing in fighting infectious diseases. Crucell's innovative technologies and creative minds drive its success.

Crucell's strong research & development (R&D) pipeline includes promising products in pre-clinical and clinical development. Product candidates include flu-mAb, an antibody product effective against a broad range of influenza virus strains, tuberculosis and malaria vaccines, as well as a rabies monoclonal antibody combination – all produced on Crucell’s unique PER.C6® human-cell technology. Crucell is actively combating twelve major infectious diseases with a range of marketed vaccines in the pediatric, travel & endemic, and respiratory fields.

As a leading independent vaccine company, Crucell continues to expand its global reach. Information regarding Crucell's strategic locations and operational details will be completed soon with the support of the company’s management. We invite the manager of Crucell to create a customized and exclusive company showcase and product listing on our platform to further enhance its market presence.